Onchocerciasis (River Blindness) Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Onchocerciasis (River Blindness) Treatment Market: By Drug Class Type (Anthelmintic drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Onchocerciasis (River Blindness) Treatment Market size is valued at USD 2.33 billion in 2021 and is expected to reach USD 3.57 billion by 2028, at a CAGR of 6.3% during the forecast period 2022-2028. Onchocerciasis, often known as river blindness, is a parasitic worm infection caused by the Onchocerca volvulus. Bumps under the skin, intense itching, and blindness are all signs of onchocerciasis. After trachoma, onchocerciasis is the second most prevalent cause of infection-related blindness. The disease is spread by infected blackflies biting humans. These black flies breed near settlements and agricultural land, where they breed along streams and fast-flowing rivers. Adult onchocerciasis worms produce microfinance (embryonic larvae) in the human body, which can travel to the eyes, skin, and other organs. The majority of people affected with this disease live in African countries. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Onchocerciasis (River Blindness) Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Onchocerciasis (River Blindness) Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Onchocerciasis (River Blindness) Treatment Market

MARKET SUMMARY
-
6.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.3%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Onchocerciasis (River Blindness) Treatment Market

  • The global Onchocerciasis (River Blindness) Treatment Market report gives comprehensive outlook on Onchocerciasis (River Blindness) Treatment Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Onchocerciasis (River Blindness) Treatment Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Merck & Co., Inc. (U.S)
  • Mayne Pharma Group (Australia)
  • Delta Pharma Ltd., (India)
  • Par Pharmaceutical Companies, Inc.(U.S)
  • Taj Pharmaceuticals Limited (India)
Onchocerciasis (River Blindness) Treatment Market

DRIVERS AND RESTRAINTS

In recent years, the onchocerciasis treatment market has been influenced by soaring market capitalization of smaller players, increasing number of strategic partnerships to scoop out the best of emerging medications or drugs, increased R&D spending by big pharma and emerging players, expanded indications for approved drugs, and rising competition between companies producing drugs for the same indications have all influenced demand. Following 15-17 years of therapy, a recent evaluation in Mali and Senegal has confirmed the primary confirmation of disposal. Following this discovery, the African Program for Onchocerciasis Control (APOC) has launched a thorough examination of the long-term effects of ivermectin treatment projects and the viability of completion in APOC-supported countries.


North-America got significant share

Onchocerciasis (River Blindness) Treatment Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

Onchocerciasis (River Blindness) Treatment Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Merck & Co., Inc. (U.S)
  • Mayne Pharma Group (Australia)
  • Delta Pharma Ltd., (India)
  • Par Pharmaceutical Companies, Inc.(U.S)
  • Taj Pharmaceuticals Limited (India)

Description

Onchocerciasis (River Blindness) Treatment Market size is valued at USD 2.33 billion in 2021 and is expected to reach USD 3.57 billion by 2028, at a CAGR of 6.3% during the forecast period 2022-2028. Onchocerciasis, often known as river blindness, is a parasitic worm infection caused by the Onchocerca volvulus. Bumps under the skin, intense itching, and blindness are all signs of onchocerciasis. After trachoma, onchocerciasis is the second most prevalent cause of infection-related blindness. The disease is spread by infected blackflies biting humans. These black flies breed near settlements and agricultural land, where they breed along streams and fast-flowing rivers. Adult onchocerciasis worms produce microfinance (embryonic larvae) in the human body, which can travel to the eyes, skin, and other organs. The majority of people affected with this disease live in African countries. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Onchocerciasis (River Blindness) Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Onchocerciasis (River Blindness) Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX